↓ Skip to main content

Dove Medical Press

Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, March 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
5 Mendeley
Title
Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility
Published in
ClinicoEconomics and Outcomes Research: CEOR, March 2021
DOI 10.2147/ceor.s297284
Pubmed ID
Authors

Elizabeth James, Holly Trautman, Stephen Thompson, Rinat Ribalov, Azhar Choudhry

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 20%
Researcher 1 20%
Unknown 3 60%
Readers by discipline Count As %
Linguistics 1 20%
Business, Management and Accounting 1 20%
Unknown 3 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2021.
All research outputs
#22,835,295
of 25,462,162 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#488
of 525 outputs
Outputs of similar age
#391,636
of 451,762 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#12
of 12 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,762 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.